1. Home
  2. DNLI vs NTCT Comparison

DNLI vs NTCT Comparison

Compare DNLI & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • NTCT
  • Stock Information
  • Founded
  • DNLI 2013
  • NTCT 1984
  • Country
  • DNLI United States
  • NTCT United States
  • Employees
  • DNLI N/A
  • NTCT N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • NTCT EDP Services
  • Sector
  • DNLI Health Care
  • NTCT Technology
  • Exchange
  • DNLI Nasdaq
  • NTCT Nasdaq
  • Market Cap
  • DNLI 2.2B
  • NTCT 2.0B
  • IPO Year
  • DNLI 2017
  • NTCT 1999
  • Fundamental
  • Price
  • DNLI $14.93
  • NTCT $26.91
  • Analyst Decision
  • DNLI Strong Buy
  • NTCT Buy
  • Analyst Count
  • DNLI 13
  • NTCT 2
  • Target Price
  • DNLI $32.64
  • NTCT $29.00
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • NTCT 469.3K
  • Earning Date
  • DNLI 11-03-2025
  • NTCT 11-06-2025
  • Dividend Yield
  • DNLI N/A
  • NTCT N/A
  • EPS Growth
  • DNLI N/A
  • NTCT N/A
  • EPS
  • DNLI N/A
  • NTCT 1.02
  • Revenue
  • DNLI N/A
  • NTCT $834,861,000.00
  • Revenue This Year
  • DNLI N/A
  • NTCT $5.30
  • Revenue Next Year
  • DNLI $94,232.03
  • NTCT $2.68
  • P/E Ratio
  • DNLI N/A
  • NTCT $26.52
  • Revenue Growth
  • DNLI N/A
  • NTCT 5.29
  • 52 Week Low
  • DNLI $10.57
  • NTCT $18.12
  • 52 Week High
  • DNLI $33.33
  • NTCT $28.30
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.86
  • NTCT 54.11
  • Support Level
  • DNLI $15.53
  • NTCT $26.28
  • Resistance Level
  • DNLI $17.02
  • NTCT $28.28
  • Average True Range (ATR)
  • DNLI 0.79
  • NTCT 0.61
  • MACD
  • DNLI -0.19
  • NTCT 0.04
  • Stochastic Oscillator
  • DNLI 0.71
  • NTCT 49.35

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

Share on Social Networks: